Table 2

Prognostic factors in MCL

VariableUnivariate analysisMultivariate analysis
HR95% CIP valueHR95% CIP value
Age (per year) 1.06* 1.05-1.07 <.001 1.06* 1.05-1.07 <.001 
Male gender 1.04 0.89-1.22 .642 1.36* 1.12-1.64 .002 
WHO performance status 1.92* 1.81-2.05 <.001 1.61* 1.47-1.76 <.001 
Elevated LDH 1.93* 1.66-2.23 <.001 1.86* 1.55-2.22 <.001 
Ann Arbor stage 1.26* 1.17-1.41 <.001 1.21* 1.07-1.35 .002 
White blood cell count (per 1 × 109/L) 1.002* 1.001-1.003 .005 1.002* 1.001-1.004 .003 
VariableUnivariate analysisMultivariate analysis
HR95% CIP valueHR95% CIP value
Age (per year) 1.06* 1.05-1.07 <.001 1.06* 1.05-1.07 <.001 
Male gender 1.04 0.89-1.22 .642 1.36* 1.12-1.64 .002 
WHO performance status 1.92* 1.81-2.05 <.001 1.61* 1.47-1.76 <.001 
Elevated LDH 1.93* 1.66-2.23 <.001 1.86* 1.55-2.22 <.001 
Ann Arbor stage 1.26* 1.17-1.41 <.001 1.21* 1.07-1.35 .002 
White blood cell count (per 1 × 109/L) 1.002* 1.001-1.003 .005 1.002* 1.001-1.004 .003 
*

P < .01.

or Create an Account

Close Modal
Close Modal